SCHEMBL24299252

SCHEMBL24299252

Cc1cccc(C)c1-c1cc(O)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ENPP2 Q13822 2/20 0.36
APEX1 P27695 1/20 0.36
TYMS P04818 2/20 0.36
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35
RHOA P61586 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CA12 O43570 3/20 0.34
CA2 P00918 3/20 0.34
CA9 Q16790 3/20 0.34
TTR P02766 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24298907 0.91 PARP1 (0.38)
SCHEMBL22509298 0.88 CYP1A2 (0.40) CYP1A2CYP2C9HPGDHSD17B10ENPP2
SCHEMBL24326406 0.87 SYK (0.40) CYP1A2CYP2C9HPGDHSD17B10APEX1
SCHEMBL24323828 0.82 PIK3CD (0.34) CYP1A2CYP2C9HPGDHSD17B10APEX1
SCHEMBL26846380 0.82 SCN4A (0.34) CYP1A2CYP2C9HPGDHSD17B10APEX1
SCHEMBL24329987 0.81 PLK1 (0.35) L3MBTL1
SCHEMBL24323158 0.81 KDM4E (0.35) CYP1A2CYP2C9HPGDHSD17B10APEX1
SCHEMBL27024729 0.80 SRC (0.44) HPGDPOLBL3MBTL1SRC
SCHEMBL22509294 0.79 AAK1 (0.34) CYP1A2CYP2C9HPGDHSD17B10APEX1
SCHEMBL27012787 0.79 SRC (0.41) HPGDSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076621-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed